MedTrace Logo

Genotyping Analysis of Acute Lymphoblastic Leukemia

NCT00961285 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2010-11-30

No results posted yet for this study

Summary

Identification of alterations potentially involved in the complex mechanisms of leukemogenesis and at the identification and validation of novel biological factors which may serve as predictors of drug-response and drug-resistance or which may be suitable for targeted therapy.

Conditions

Sponsors & Collaborators

  • University of Bologna

    lead OTHER

Principal Investigators

  • Giovanni Martinelli, prof. · University of Bologna

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-03-31
Primary Completion
2011-12-31
Completion
2012-12-31

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00961285 on ClinicalTrials.gov